All New Diabetics In Scania - ANDIS

ANDIS is a combined research and quality assurance project with the long term aim of introducing precision medicine in diabetes. In connection with a visit to your doctor or diabetes nurse personal identification number, name, address, date of diagnosis, initial and current diabetes treatment, time of start of diabetes treatment, weight and height, possible diabetes during pregnancy, information on the prevalence of diabetes in the family as well as information about the country of birth of the study person and his/her parents was registered. Upon registration, blood samples for determination of GAD antibodies and C-peptide as well as for DNA analysis are taken. The DNA sample is used to classify the disease into subtypes, and to investigate hereditary causes of diabetes, diabetic complications and other medical conditions associated with diabetes. One blood sample is stored for possible future analysis. If the study person previously have given consent for registration of his or her data in the National Diabetes Register (NDR) the study person is asked whether this information can be linked to the ANDIS database on an annual basis. The ANDIS registry is also linked with the Region Skåne Care Database and the register for prescribed drugs to add information about the use of medications and diabetic complications. Ongoing study, currently> 11,000 patients (January 2015). Purpose: To register all new cases of diabetes in Scania and improve diagnosis and treatment strategies. The cohort cover the full spectrum of diabetes in Region Skåne. It has unique representation since a majority of all health care providers, hospitals and clinics participate.